Misconduct Without Scienter Can’t Support Qui Tam Complaint
In a second defeat for the relator, a New York district court dismissed a qui tam complaint alleging that McKesson used various market analysis tools to induce oncology practices to buy its products.
🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every case digest, six days a week.
$750/year